Reliance Pharma Fund - Direct (D)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 13 Jul 2018 65.56 -0.51
(-0.77%)

NAV High-Low (in Rs)

ONE Mth 2143.66
2143.66
52-WEEk 1461.39
2143.66

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 0.26 2.94 0.09 9.91 2.46
Sensex 2.48 2.25 5.63 14.06 30.69
Nifty 2.29 1.49 3.16 11.4 30.25

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid 6.00 (Rs) 24-02-2018
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 30 Jun 2018
Category Share (%)
Cash & Cash Equivalent 0.00
CBLO 1.69
Derivatives 0.34
Equity 97.90
Net CA & Others 0.07
› More
   As On 30 Jun 2018
Sector Name Amount
Finance & Investments 1.01
Healthcare 10.41
NA 2.10
Pharmaceuticals - Indian - Bulk Drugs 16.18
Pharmaceuticals - Indian - Bulk Drugs & Formln 56.11
Pharmaceuticals - Multinational 14.19
› More
   As On 30 Jun 2018
Company Name
Sun Pharma.Inds. 11.05
Cipla 9.78
Dr Reddy's Labs 9.21
Divi's Lab. 8.59
Aurobindo Pharma 8.35
Lupin 7.59
Abbott India 7.37
Biocon 6.95
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com